174 related articles for article (PubMed ID: 8544456)
21. [Medullary cancer of the thyroid. Experience at the Hospital de Valdivia].
Pérez JA; Salinas P; Poblete MT; Silva R; Cardemil B; Krauskopf V; Soto C
Rev Med Chil; 1996 Jun; 124(6):707-14. PubMed ID: 9041728
[TBL] [Abstract][Full Text] [Related]
22. [Decision making in postoperative incidentally found small C-cell-carcinoma].
Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
[TBL] [Abstract][Full Text] [Related]
23. [Long-term course of medullary thyroid gland carcinoma].
Wagner HE; Ruchti C; Studer M; Haldemann AR; Kinser J; Bürgi U
Swiss Surg; 1996; 2(5):181-6. PubMed ID: 8963841
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Meijer JA; le Cessie S; van den Hout WB; Kievit J; Schoones JW; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2010 Apr; 72(4):534-42. PubMed ID: 19563448
[TBL] [Abstract][Full Text] [Related]
25. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
26. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
28. Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival?
Brumsen C; Haak HR; Goslings BM; van de Velde CJ
Henry Ford Hosp Med J; 1992; 40(3-4):271-5. PubMed ID: 1483874
[TBL] [Abstract][Full Text] [Related]
29. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
[TBL] [Abstract][Full Text] [Related]
30. [Multiple endocrine type 2 neoplasia in 3 families].
Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
[TBL] [Abstract][Full Text] [Related]
31. Medullary carcinoma of the thyroid gland.
Gogas J; Markopoulos C; Skandalakis P; Sechas M
Am Surg; 1987 Jun; 53(6):347-9. PubMed ID: 3579051
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
[TBL] [Abstract][Full Text] [Related]
37. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
38. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
Allanic H
Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
40. [Medullary carcinoma of the thyroid gland. Personal experience].
Neradilová M; Nĕmec J; Vlcek P; Soutorová M; Bednár J
Cesk Pediatr; 1992 Aug; 47(8):449-52. PubMed ID: 1394547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
